News
The weight-loss drug market is heating up with the introduction of GLP-1 pills. Novo Nordisk’s NVO Wegovy and Eli Lilly’s LLY Zepbound have been dominating this market and several other ...
These exchange-traded funds won't even need constant monitoring. In fact, you'd be better served in the long run by not ...
17d
Zacks Investment Research on MSNPharma ETFs in Focus on Trump's Drug Price OverhaulPresident Donald Trump announced plans to sign an executive order aimed at significantly reducing U.S. prescription drug prices by 30% to 80%. The initiative, known as the "most favored nation" policy ...
Scott Olson / Getty Images The Roundhill GLP-1 & Weight Loss ETF and the Amplify Weight Loss Drug & Treatment ETF were launched in May to tap into the recent popularity of obesity drugs.
Get detailed information about the Huatai-PB Hang Seng Invt Drug (QDII) ETF. View the current 520500 stock price chart, historical data, premarket price, dividend returns and more.
E Fund CSI Brand Name Drug Industry ETF has an average Morningstar Sustainability Rating of 3 globes, indicating that the ESG risk of holdings in its portfolio is similar to that of its peers in ...
Sources: FactSet, Dow Jones ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Sources: FactSet, Dow Jones Bonds: Bond quotes are updated in real-time. Sources: FactSet, Tullett ...
The proposal is expected to face strong pushback once again from drug manufacturers (read: A Look at Pharma ETFs After Strong Q1 Earnings). This policy has immediate implications for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results